Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Phase II study of 90Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma.

Lossos IS, Fabregas JC, Koru-Sengul T, Miao F, Goodman D, Serafini AN, Hosein PJ, Stefanovic A, Rosenblatt JD, Hoffman JE.

Leuk Lymphoma. 2014 Nov 20:1-6. [Epub ahead of print]

PMID:
25315074
[PubMed - as supplied by publisher]
2.

A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression.

Li D, Pant S, Ryan DP, Laheru D, Bahary N, Dragovich T, Hosein PJ, Rolfe L, Saif MW, LaValle J, Yu KH, Lowery MA, Allen A, O'Reilly EM.

Pancreatology. 2014 Sep-Oct;14(5):398-402. doi: 10.1016/j.pan.2014.07.003. Epub 2014 Jul 18.

PMID:
25278310
[PubMed - in process]
3.

Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system.

Hosein PJ, Echenique A, Loaiza-Bonilla A, Froud T, Barbery K, Rocha Lima CM, Yrizarry JM, Narayanan G.

J Vasc Interv Radiol. 2014 Aug;25(8):1233-1239.e2. doi: 10.1016/j.jvir.2014.04.007. Epub 2014 May 24.

PMID:
24861662
[PubMed - in process]
4.

LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.

Lossos C, Bayraktar S, Weinzierl E, Younes SF, Hosein PJ, Tibshirani RJ, Sutton Posthumus J, DeAngelis LM, Raizer J, Schiff D, Abrey L, Natkunam Y, Lossos IS.

Br J Haematol. 2014 Jun;165(5):640-8. doi: 10.1111/bjh.12801. Epub 2014 Feb 26. Review.

PMID:
24571259
[PubMed - indexed for MEDLINE]
5.

A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.

Hosein PJ, Maragulia JC, Salzberg MP, Press OW, Habermann TM, Vose JM, Bast M, Advani RH, Tibshirani R, Evens AM, Islam N, Leonard JP, Martin P, Zelenetz AD, Lossos IS.

Br J Haematol. 2014 May;165(3):358-63. doi: 10.1111/bjh.12753. Epub 2014 Jan 27.

PMID:
24467658
[PubMed - indexed for MEDLINE]
6.

Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer.

Palacio S, Loaiza-Bonilla A, Kittaneh M, Kyriakopoulos C, Ochoa RE, Escobar M, Arango B, Restrepo MH, Merchan JR, Rocha Lima CM, Hosein PJ.

Anticancer Res. 2014 Jan;34(1):301-6.

PMID:
24403478
[PubMed - indexed for MEDLINE]
7.

Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.

Narayanan G, Hosein PJ, Arora G, Barbery KJ, Froud T, Livingstone AS, Franceschi D, Rocha Lima CM, Yrizarry J.

J Vasc Interv Radiol. 2012 Dec;23(12):1613-21. doi: 10.1016/j.jvir.2012.09.012.

PMID:
23177107
[PubMed - indexed for MEDLINE]
8.

Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab.

Warsch S, Hosein PJ, Morris MI, Teomete U, Benveniste R, Chapman JR, Lossos IS.

Int J Hematol. 2012 Aug;96(2):274-8. doi: 10.1007/s12185-012-1118-6. Epub 2012 Jun 9.

PMID:
22684926
[PubMed - indexed for MEDLINE]
9.

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.

Hosein PJ, Macintyre J, Kawamura C, Maldonado JC, Ernani V, Loaiza-Bonilla A, Narayanan G, Ribeiro A, Portelance L, Merchan JR, Levi JU, Rocha-Lima CM.

BMC Cancer. 2012 May 29;12:199. doi: 10.1186/1471-2407-12-199.

PMID:
22642850
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.

Hosein PJ, de Lima Lopes G Jr, Pastorini VH, Gomez C, Macintyre J, Zayas G, Reis I, Montero AJ, Merchan JR, Rocha Lima CM.

Am J Clin Oncol. 2013 Apr;36(2):151-6. doi: 10.1097/COC.0b013e3182436e8c.

PMID:
22307213
[PubMed - indexed for MEDLINE]
11.

A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma.

Warsch S, Hosein PJ, Maeda LS, Alizadeh AA, Lossos IS.

Leuk Lymphoma. 2012 Jul;53(7):1299-305. doi: 10.3109/10428194.2011.649476. Epub 2012 Jan 31.

PMID:
22185662
[PubMed - indexed for MEDLINE]
12.

A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.

Hosein PJ, Craig MD, Tallman MS, Boccia RV, Hamilton BL, Lewis JJ, Lossos IS.

Am J Hematol. 2012 Jan;87(1):111-4. doi: 10.1002/ajh.22232. Epub 2011 Nov 12. No abstract available.

PMID:
22081459
[PubMed - indexed for MEDLINE]
13.

Utility of positron emission tomography scans in mantle cell lymphoma.

Hosein PJ, Pastorini VH, Paes FM, Eber D, Chapman JR, Serafini AN, Alizadeh AA, Lossos IS.

Am J Hematol. 2011 Oct;86(10):841-5. doi: 10.1002/ajh.22126. Epub 2011 Aug 22.

PMID:
21922524
[PubMed - indexed for MEDLINE]
14.

Severe colitis associated with docetaxel use: A report of four cases.

Carrion AF, Hosein PJ, Cooper EM, Lopes G, Pelaez L, Rocha-Lima CM.

World J Gastrointest Oncol. 2010 Oct 15;2(10):390-4. doi: 10.4251/wjgo.v2.i10.390.

PMID:
21160890
[PubMed]
Free PMC Article
15.

The evolving role of F-FDG PET scans in patients with aggressive non-Hodgkin's lymphoma.

Hosein PJ, Lossos IS.

European J Clin Med Oncol. 2010 Feb;2(1):131-138.

PMID:
22140415
[PubMed]
Free PMC Article
16.
17.

Role of combined-modality therapy in the management of locally advanced rectal cancer.

Hosein PJ, Rocha-Lima CM.

Clin Colorectal Cancer. 2008 Nov;7(6):369-75. doi: 10.3816/CCC.2008.n.049. Review.

PMID:
19036689
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk